Home Biolexis

Biolexis

In operation
Undisclosed
Biotechnology, Vaccine Developer
Basic
Enterprise Profile

Basic Information

Biolexis is an emerging biotechnology and vaccine company with the capability to develop and commercialize products for the global market. The company, a wholly-owned subsidiary of Stelis, focuses on building and licensing a portfolio of advanced biosimilars, peptides, and vaccines.
Biolexis Private Limited
Bangalore,Karnataka,India
unclear
--
--
cs@stelis.com

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Biotechnology
Concept
Disease Prevention
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)